 | Tacrine | IC50 | 36.0 [1] |
| Tacrine | Ki | 7.0 [1], 8.7 [2], 8.72 [3] |
 | Donepezil | IC50 | 5580.0 [1] |
| Donepezil | Ki | 12540.0 [1] |
 | Galantamine | IC50 | 10000.0 [1] |
| Galantamine | Ki | 192.47 [1], 192.5 [2], 28290.0 [3] |
 | Physostigmine | IC50 | 73.0 [1] |
| Physostigmine | Ki | 5000.0 [1] |
 | Rivastigmine | IC50 | 260.0 [1] |
 | (1S,9R,13E)-1-Amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one | IC50 | 10000.0 [1] |
| (1S,9R,13E)-1-Amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one | Ki | 1000.0 [1] |
 | 4,4'-(3-Oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenylbenzenaminium) dibromide | IC50 | 255000.0 [1], 354000.0 [2] |
| 4,4'-(3-Oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenylbenzenaminium) dibromide | Ki | 50.0 [1] |
 | 7-Methoxy-1,2,3,4-tetrahydroacridin-9-amine | IC50 | 21000.0 [1] |
 | Propidium iodide | IC50 | 13200.0 [1] |
 | Bis(7)-Tacrine | IC50 | 5.66 [1], 9.03 [2], 38.3 [3], 54.0 [4] |
| Bis(7)-Tacrine | Ki | 0.16 [1] |
 | Memoquin | IC50 | 1440.0 [1] |
 | Tacrine hydrochloride | IC50 | 23.0 [1], 40.0 [2], 43.9 [3], 44.0 [4] |
 | Benzil | IC50 | 100000.0 [1] |
| Benzil | Ki | 100000.0 [1] |
 | Caproctamine | IC50 | 11600.0 [1], 11748.98 [2], 85113800000000.0 [3] |
 | [(8Bs)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate | IC50 | 1300.0 [1], 1560.0 [2] |
 | Pyridostigmine bromide | IC50 | 900.0 [1], 1000.0 [2], 16000000.0 [3] |
 | Phenserine | IC50 | 1300.0 [1], 1560.0 [2], 2500.0 [3] |
 | Eptastigmine | IC50 | 0.69 [1], 5.0 [2] |
 | Ethopropazine hydrochloride | IC50 | 1600.0 [1] |
| Ethopropazine hydrochloride | Ki | 12100000.0 [1] |
 | 9-Amino-6-chloro-1,2,3,4-tetrahydro-acridine | IC50 | 114.0 [1], 846.9 [2], 1730.0 [3], 1780.0 [4] |
 | 2H-1-Benzopyran-2-one, 6,7-dimethoxy-3-(4-((methyl(phenylmethyl)amino)methyl)phenyl)- | IC50 | 48900.0 [1] |
 | 7-Chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine;hydrochloride | IC50 | 175.0 [1], 181.0 [2], 236.0 [3] |
 | N-[8-(1,2,3,4-Tetrahydroacridin-9-ylthio)octyl]-1,2,3,4-tetrahydroacridin-9-amine | IC50 | 0.77 [1] |
| N-[8-(1,2,3,4-Tetrahydroacridin-9-ylthio)octyl]-1,2,3,4-tetrahydroacridin-9-amine | Ki | 1.65 [1] |
 | N-[[1-(2,3-Dihydro-1H-inden-2-yl)piperidin-3-yl]methyl]-N-(2-methoxyethyl)naphthalene-2-carboxamide | IC50 | 21.0 [1], 21.3 [2] |
 | Neostigmine | IC50 | 16300.0 [1], 26100.0 [2], 49100.0 [3] |
 | Edrophonium chloride | IC50 | 1370000.0 [1] |
 | Bambuterol | IC50 | 3.0 [1], 4.29 [2] |
 | Huprine Y | IC50 | 153.0 [1], 175.0 [2], 181.0 [3] |
 | (1R)-7-Chloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine | IC50 | 159.0 [1] |
| (1R)-7-Chloro-15-ethyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine | Ki | 120.0 [1] |
 | Lipocrine | IC50 | 10.8 [1], 11.0 [2] |
 | 4-Isopropylphenserine | IC50 | 50.0 [1] |
 | Cymserine | IC50 | 50.0 [1], 51.0 [2] |
 | [(8Bs)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-(2-methylphenyl)carbamate | IC50 | 1950.0 [1] |
 | Ethyl 5-amino-4-(4-methoxyphenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate | IC50 | 100000.0 [1] |
 | 3-(2-Thiophen-2-yl-2,3-dihydro-1,5-benzothiazepin-4-yl)phenol | IC50 | 3970.0 [1] |
 | Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate | IC50 | 100000.0 [1] |
 | Ethyl 5-amino-4-(4-fluorophenyl)-2-methyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate | IC50 | 100000.0 [1] |
 | Ethyl 5-amino-2-methyl-4-(4-methylphenyl)-1,4,6,7,8,9-hexahydrobenzo[b][1,8]naphthyridine-3-carboxylate | IC50 | 100000.0 [1] |
 | (E)-N-[2-(1-Benzylpiperidin-4-yl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamide | IC50 | 784.0 [1], 930.0 [2], 1220.0 [3] |
 | Dimethylphysostigmine | IC50 | 420.0 [1], 3000.0 [2] |
 | 3-[2-(2-Methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenol | IC50 | 4650.0 [1] |
 | 3-[2-(3-Chlorophenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenol | IC50 | 29400.0 [1] |
 | 3-[2-(4-Chlorophenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenol | IC50 | 76600.0 [1], 76900.0 [2], 79600.0 [3] |
 | 3-[2-(4-Methylphenyl)-2,3-dihydro-1,5-benzothiazepin-4-yl]phenol | IC50 | 75200.0 [1] |
 | 3-[2-[4-(Dimethylamino)phenyl]-2,3-dihydro-1,5-benzothiazepin-4-yl]phenol | IC50 | 34400.0 [1] |
 | 3-(2-Phenyl-2,3-dihydro-1,5-benzothiazepin-4-yl)phenol | IC50 | 142100.0 [1], 1421000.0 [2] |
 | (2-Chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-dimethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-dimethylazanium | IC50 | 6800.0 [1], 6820.0 [2], 7000.0 [3] |
 | Quercetin | IC50 | 420760.0 [1] |
| Quercetin | Ki | 68000.0 [1] |
 | Lipoic acid | IC50 | 1000000.0 [1] |
 | 2,3-Butanedione | Ki | 100000.0 [1] |
 | Rhein | IC50 | 17000.0 [1] |
 | Benzoin | Ki | 100000.0 [1] |
 | Methoctramine | IC50 | 977.24 [1], 1023290000000000.0 [2] |
 | Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)- | IC50 | 733.0 [1], 980.0 [2] |
 | Benextramine | IC50 | 6165.95 [1], 162181000000000.0 [2] |
 | Profenamine | IC50 | 300.0 [1] |
| Profenamine | Ki | 20.0 [1] |
 | 1-Phenyl-1,2-propanedione | Ki | 100000.0 [1] |
 | CycloSal-d4TMP | IC50 | 770.0 [1] |
 | Deoxyvasicinone | IC50 | 25100.0 [1], 45100.0 [2] |
 | CID 53378764 | IC50 | 1700.0 [1], 3300.0 [2] |
 | (1S,13S)-7-Chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine | IC50 | 222.0 [1] |
 | Xanthostigmine | IC50 | 48.0 [1], 48000.0 [2] |
 | 5-Methyl-cyclosal-d4TMP | IC50 | 4600.0 [1] |
 | Tolserine | IC50 | 1950.0 [1] |
 | (13S)-7-Fluoro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine | IC50 | 197.0 [1] |
 | 3-Methyl-2-(4-methylpiperazin-1-yl)-N-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptyl]quinoline-4-carboxamide | IC50 | 40.0 [1] |
 | (+)-Phenserine | IC50 | 23490.0 [1], 23500.0 [2] |
 | 3-[7-[N-Methyl-3-(methylcarbamoyloxy)benzylamino]heptyloxy]-9H-xanthene-9-one | IC50 | 16.5 [1], 16500.0 [2] |
 | 1,2-Bis(3,5-difluorophenyl)ethane-1,2-dione | Ki | 100000.0 [1] |
 | 4,4'-Difluorobenzil | Ki | 100000.0 [1] |
 | Rac-huprine H4 | IC50 | 79.3 [1] |
 | Rac-huprine H1 | IC50 | 126.0 [1], 316.0 [2] |
 | Rac-huprine H5 | IC50 | 208.0 [1], 347.0 [2] |
 | [(8Bs)-3,8b-dimethyl-1,2,3a,4-tetrahydropyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate | IC50 | 516.0 [1], 516.3 [2] |
 | Saligcinnamide | IC50 | 4840.0 [1] |
| Saligcinnamide | Ki | 6600.0 [1] |
 | 6-[Ethyl-[(2-methoxyphenyl)methyl]amino]-N-[8-[6-[ethyl-[(2-methoxyphenyl)methyl]amino]hexanoyl-methylamino]octyl]-N-methylhexanamide | IC50 | 2238.72 [1], 2250.0 [2] |
 | Methylbis[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]amine | IC50 | 10.4 [1] |
| Methylbis[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]amine | Ki | 12.13 [1] |
 | [(8Bs)-4-benzyl-3,8b-dimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate | IC50 | 21.8 [1] |
 | 1,2-Bis(3,4,5-trifluorophenyl)ethane-1,2-dione | Ki | 100000.0 [1] |
 | 1,4-Bis(phenylglyoxaloyl)benzene | Ki | 100000.0 [1] |
 | N'-Methyl-N-(1,2,3,4-tetrahydroacridin-9-yl)-N'-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]butane-1,4-diamine | Ki | 0.82 [1] |
 | Axillaridine A | IC50 | 2490.0 [1] |
| Axillaridine A | Ki | 2150.0 [1] |
 | {4-[(Benzylmethylamino)methyl]phenyl}-(4-methoxyphenyl)methanone | IC50 | 10000.0 [1], 100000.0 [2] |
 | Bisnorcymserine | IC50 | 1.0 [1] |
Calculator
